Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

PHASE4CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

June 30, 2007

Study Completion Date

November 30, 2007

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

rituximab

Dose, schedule,and duration specified in protocol

Trial Locations (45)

10466

Our Lady of Mercy Medical Center, The Bronx

15232

University of Pittsburth Cancer Centers, Pittsburgh

61801

Carle Clinic Association, Urbana

90033

USC KECK School of Medicine, Los Angeles

96814

Radiant Research, Honolulu

02111

Tufts - New England Medical Center, Boston

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

Unknown

Research Site, Graz

Research Site, Brno

Research Site, Hradec Králové

Research Site, Olomouc

Research Site, Prague

Research Site, Dijon

Research Site, Lyon

Research Site, Paris

Research Site, Strasbourg

Research Site, Berlin

Research Site, Bonn

Research Site, Frankfurt

Research Site, Giessen

Research Site, Hamburg

Research Site, Koblenz

Research Site, Mainz

Research Site, Mutlangen

Research Site, Tübingen

Research Site, Kaunas

Research Site, Klaipėda

Research Site, Vilnius

Research Site, Brasov

Research Site, Bucharest

Research Site, Cluj-Napoca

Research Site, Craiova

Research Site, Moscow

Research Site, Nizhny Novgorod

Research Site, Obninsk

Research Site, Saint Petersburg

Research Site, Yekaterinburg

Research Site, Stockholm

Research Site, Gaziantep

Research Site, Izmir

Research Site, Kayseri

Research Site, Leeds

Research Site, Leicester

Research Site, Manchester

Research Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY